Before a potential new treatment can reach patients, it goes through several clinical trial phases that test the treatment for both safety and effectiveness. This process can be long and costly. Together, clinical trial phases take six to seven years on average. The average cost to research and develop each successful drug is estimated to be $2.6 billion. The importance of selecting the right clinical trial Site and Site feasibility within clinical trials is essential to accelerate the clinical trial process overall. Financial resources and time are at stake in the clinical trial Site selection process. Today, LINEA System, LLC will be discussing Site Identification, the importance of selecting the right clinical trial Site, and a solution that optimizes the Site identification process.
What is Site Identification & Feasibility?
Within the clinical trial set-up process and trial planning, two crucial components are Site identification and feasibility. The tasks associated with Site identification, feasibility, and activation intertwine into the clinical trial protocol which is developed before Site identification can take place. Site ID is the process of selecting the right clinical trial Site to handle the trial. In addition, Site feasibility evaluates the selected Site to ensure the Site has the proper resources and facilities to ensure the clinical trial will develop effectively to accomplish the objectives set.
Importance of Selecting the Right Clinical Trial Sites
When going through the trial planning process many may wonder about the significance of Site identification and feasibility. A multitude of steps, such as research on patients and Site data are involved which makes the process tedious. However, the significance of Site identification is crucial as it can save ample time and financial resources.
Identifying quality investigative Sites is essential as it fuels optimal patient recruitment. Specifically, patient recruitment that can be done within the time frame required and with the correct patients that can participate in the trial. Selecting the right clinical trial Site fuels patient recruitment and the quality of the trial and the data obtained ultimately. Patient recruitment is so crucial to trials as it can affect the entire trial. To put into perspective, approximately 80% of clinical trials are delayed or closed because of problems with recruitment.
If the Site identification process is done poorly it can hurt the sponsor’s resources and the overall quality of the trial. Here are some other statistics to stress the importance of quality Site ID: 9 out of 10 trials require the original timeline to be doubled in order to meet enrollment goals; 11% of research Sites fail to enroll a single patient; Delays can cost sponsors between $600,000 and $8 million in opportunity cost for each day that a trial delays a product’s development and launch.
How to Select the Right Clinical Trial Sites: AcceleTrial®
Now that we have discussed Site identification and the significance of selecting the right clinical trial Sites, how can you select the proper Sites? To choose the proper clinical trial Sites you can utilize a study start-up system (SSUS) like AcceleTrial®. AcceleTrial® takes the guesswork out of clinical trial Site identification and activation. Our Study Start-Up System is based on the foundation of objective Site data rather than self-identification. AcceleTrial®, enables sponsors to streamline and automate the study start-up process to reduce the time it takes to launch clinical trials and patient recruitment. When a sponsor identifies the right investigators and clinical study Site first, the trial begins faster and critical medicine gets to patients who need it most.
The AcceleTrial® platform, in combination with LINEA System’s proprietary algorithms, allows LINEA System’s clients to quickly access, extract, organize, index, and integrate critical data on over 300,000+ clinical investigator Sites. The database allows Sponsors to access specialized data without having to spend extensive time researching such information. The Study Start-Up System has an automated workflow that allows sponsors to save time and resources and allocate such to other priorities. With such a database, a Sponsor can reap the benefits of selecting the right clinical trial Sites through an accessible system making the process efficient and effective. We believe AcceleTrial® can make an industry wide impact on the clinical trial process, accelerate the rate of bringing new medicines to market, and find the right Sites using objective data.
Now that you have the knowledge and tools to select the right clinical trial Sites the Site ID process can be done with ease.
This post was all about the importance of selecting the right clinical trial Sites.
Other Posts You May Like…
